Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women

Hepatology

Volumn 36, Issue 1, 2002, Pages 156-163

  Yu, Ming Whei ^a   Yang, Yu Ching ^a   Yang, Shi Yi ^a   Chang, Hung Chuen ^a   Liaw, Yun Fan ^b   Lin, Shi Ming ^b   Liu, Chun Jen ^c   Lee, Shou Dong ^d   Lin, Chih Lin ^e   Chen, Pei Jer ^c   Lin, Shee Chan ^f   Chen, Chien Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e JEN AI HOSPITAL   (Taiwan)

^f MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ANDROGEN RECEPTOR; CYTOSINE; GUANINE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; EXON; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; HIGH RISK POPULATION; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; TAIWAN;

EID: 84984573456     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.33897     Document Type: Article

References (43)

1. Hepatitis B and C viruses in the development of hepatocellular carcinoma
2. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives
3. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan
4. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma
5. Cytochrome P450 2EI and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma
6. Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: Independent and interactive effects
7. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers
8. Role of N-acetyltransferase polymorphisms in hepatitis B-related hepatocellular carcinoma: Impact of smoking on risk
9. Elevated serum testosterone levels and risk of hepatocellular carcinoma
10. Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma
11. Serum testosterone: Estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients
12. Effect of neonatal castration on liver tumor induction by N-2-fluorenylacetamide in suckling BALB/c mice
13. Influence of adrenocortical, androgenic, and anabolic hormones on the development of carcinoma and cirrhosis of the liver in AXC rats fed N-2-fluorenyldiacetamide
14. Modifying role of partial hepatectomy and gonadectomy in ethylnitrosourea-induced hepatocarcinogenesis
15. Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous
16. Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice
17. HBx gene of hepatitis B virus induces liver cancer in transgenic mice
18. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
19. Androgen metabolism and prostate cancer: Establishing a model of genetic susceptibility
20. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function
21. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length
22. Androgen receptors in hepatocellular carcinoma and surrounding parenchyma
23. Androgen and estrogen receptors in hepatocellular carcinoma and the surrounding liver in women
24. Studies on the subtypes of hepatitis B surface antigendemonstration of vertical and intrafamilial transmission of hepatitis B virus
25. Isolation of DNA from biological specimens without extraction with phenol
26. A simple salting out procedure for extracting DNA from human nucleated cells
27. Mutational analysis: Known mutations
28. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
29. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat
30. Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years
31. No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer
32. Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer
33. The androgen receptor and genetic susceptibility to ovarian cancer: Results from a case series
34. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells
35. Breast cancer susceptibility gene 1 (BRCA1) is a coactivator of the androgen receptor
36. Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells
37. From estrogen to androgen receptor: A new pathway for sex hormones in prostate
38. β-Catenin affects androgen receptor transcriptional activity and ligand specificity
39. Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions
40. Genes regulated by androgens in the rat ventral prostate
41. 3 actions in LNCaP human prostate cancer cells are androgen-dependent
42. Gene activation in the X-chromosome of the mouse (Mus musculus L.)
43. Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: Interaction of inherited susceptibility and hepatitis B viral infection